Company Analysis

Cyclerion Therapeutics, Inc. (CYCN)

Nasdaq: CYCN · Pharmaceutical Preparations · Cambridge, MA · filing with the SEC since 2018
Grade4.9
◀ Past 4.2● Present 5.3▶ Future 5.1
1 est.

Filings

255 filings since 2017 beside 138 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 36 days after the quarter ended. The proxy statement was last filed Oct 15, 2026.

Filings a yearinsider forms included
8053603945213158
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 5 times in the last 36 months, the newest Sep 11, 2026.SEC letters: 7 in the last 36 months, the newest May 13, 2025.
Insider forms 138

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 10, 2026 SCHEDULE 13G Large holder notice
Nov 9, 2026 S-8 Employee stock plan registration
Nov 5, 2026 10-Q Quarterly report Sep 30, 2026
Nov 5, 2026 8-K items 2.02, 9.01 Results released · Current report
Oct 15, 2026 SCHEDULE 13G/A Large holder update, amended
Oct 15, 2026 DEF 14A Proxy statement Nov 13, 2026
Oct 7, 2026 SCHEDULE 13G/A Large holder update, amended
Oct 5, 2026 PRE 14A Preliminary proxy statement
Sep 18, 2026 SCHEDULE 13G Large holder notice
Sep 16, 2026 SCHEDULE 13G Large holder notice
Sep 15, 2026 SCHEDULE 13D Activist holder notice
Sep 11, 2026 SCHEDULE 13D Activist holder notice
Aug 27, 2026 8-K items 5.07, 8.01, 9.01 Shareholder vote; Other event · Current report Aug 26, 2026
Aug 25, 2026 425 Merger communication
Aug 25, 2026 8-K item 8.01 Other event · Current report
Aug 14, 2026 SCHEDULE 13G Large holder notice
Aug 14, 2026 SCHEDULE 13G Large holder notice
Aug 12, 2026 425 Merger communication
Aug 10, 2026 425 Merger communication
Aug 6, 2026 425 Merger communication
Aug 4, 2026 10-Q Quarterly report Jun 30, 2026
Aug 3, 2026 425 Merger communication
Jul 24, 2026 EFFECT Registration effective
Jul 24, 2026 424B3 Shelf offering
Jul 22, 2026 S-4/A Merger or exchange registration, amended
Jul 20, 2026 SCHEDULE 13D/A Activist holder update, amended
Jul 10, 2026 425 Merger communication
Jul 10, 2026 S-4/A Merger or exchange registration, amended
Jun 9, 2026 S-4/A Merger or exchange registration, amended
May 12, 2026 10-Q Quarterly report Mar 31, 2026
May 7, 2026 SCHEDULE 13G Large holder notice
Apr 30, 2026 10-K/A Annual report, amended Dec 31, 2025
Apr 20, 2026 S-4 Merger or exchange registration
Apr 1, 2026 425 Merger communication
Apr 1, 2026 8-K items 1.01, 5.01, 5.02, 7.01, 9.01 Major agreement signed; Change of control; Officer or director change; Investor disclosure (Regulation FD) · Current report
Mar 30, 2026 10-K Annual report Dec 31, 2025
Feb 17, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Jan 6, 2026 8-K items 1.01, 7.01, 9.01 Major agreement signed; Investor disclosure (Regulation FD) · Current report Jan 3, 2026
Dec 1, 2025 8-K item 8.01 Other event · Current report
40 of 255 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton CYCN · research, not advice